Hypoalbuminemia
104 results
1 - 100
Hypoalbuminemia
Protein, total- Phenytoin
Nephrotic Syndrome- Glomerulonephropathies
- Protein-losing enteropathy
- Hypoparathyroidism
- Decreased anion gap
- Hypothyroidism
etoposide- etoposide phosphate
- cobimetinib
- elotuzumab
- lurbinectedin
- polatuzumab vedotin
- larotrectinib
- capmatinib
- loncastuximab tesirine
- tepotinib
- Ascites
- Hypoparathyroidism
- irinotecan liposomal
- decitabine/cedazuridine
- dinutuximab
- moxetumumab pasudotox
- denileukin diftitox
- Calcium, serum or plasma
- adagrasib
- dacomitinib
- tagraxofusp
- avapritinib
- duvelisib
- teclistamab
- fruquintinib
- ensartinib
- tafasitamab
- talquetamab
- Nephritic Syndrome
- pemigatinib
- naxitamab
- infigratinib
- bezafibrate
- elranatamab
- amivantamab
- futibatinib
- tebentafusp
- daunorubicin/cytarabine liposomal
- lorlatinib
- sirolimus (protein bound)
- Kawasaki Disease
- Eating Disorders
- axitinib
- blinatumomab
- atezolizumab
- midostaurin
- alpelisib
- selumetinib
- entrectinib
- mogamulizumab
- tisotumab vedotin
- mobocertinib
- mitoMYcin
- pegfilgrastim
- Hydrocele
- durvalumab
- pertuzumab/trastuzumab/hyaluronidase
- acitretin
- Lactate
- Glomerulonephritis
- trabectedin
- phenytoin
- dostarlimab
- Ascites (expanded list)
- Hypocalcemia
- tremelimumab
- ACID–BASE DISTURBANCE: LABORATORY CHARACTERISTICS OF PRIMARY OR SINGLE ACID–BASE DISTURBANCE
- decitabine
- Acidosis
- FENTANYL (transmucosal)
- Feeding Tube Complications
- PHARMACOKINETIC PARAMETERS
- aldesleukin
- trametinib